További tájékoztatást szeretne?
Available on the VIDAS® 3 immunoanalyzer, VIDAS® TB-IGRA is a whole-blood test for the diagnosis of Mycobacterium tuberculosis infection.
További tájékoztatást szeretne?
Adequate diagnosis and treatment of Latent Tuberculosis Infection (LTBI) is one of the critical components of the World Health Organization’s End TB Strategy, essential to prevent the development of Active Tuberculosis disease and stop the spread of Tuberculosis.
Our new TB Interferon-Gamma Release Assay, VIDAS® TB-IGRA, offers a simple, efficient, and reliable solution to perform in-house diagnosis of TB infection.
Gain in efficiency by managing
|
Detect more TB-infected individuals*Provide reliable results for TB infection
|
* Compared with QuantiFERON-TB Gold Plus (QFT-Plus) - QuantiFERON® is a trademark belonging to Cellestis - See PERFORMANCE tab for further details
** Compared to the gold standard: culture
The clinical performance characteristics of the VIDAS® TB-IGRA assay were evaluated on two populations: patients with active TB and persons at mixed risk of Mtb infection.
ON ACTIVE TB POPULATION
The VIDAS® TB‑IGRA assay gave
than the comparative assay.
ON POPULATION AT EXTREMELY LOW LEVEL OF TB INFECTION **
High capacity to identify active TB patients |
ON POPULATION WITH MIXED RISK OF TB INFECTION***
As there is no gold standard for the diagnosis of individuals with Latent TB Infection (LTBI), PPA and NPA with the comparative assay were determined.
Detect more TB-infected individuals as risk becomes greater |
Rate of positive results was statistically higher (α=5%) for the VIDAS® TB‑IGRA assay than for the QFT®‑Plus assay (p‑value < 0.0001).
As the TB exposure risk increases, VIDAS® TB IGRA detects more positive samples reflecting a stronger association with the expected likelihood of Latent TB Infection
VIDAS® TB-IGRA assay provides fewer indeterminate results***,
HIGH CAPACITY TO GIVE VALID, INTERPRETED RESULTS TO CLINICIANS
The rate of indeterminate results was statistically lower (α=5%) for the VIDAS® TB‑IGRA assay than for the QFT®‑Plus assay (p‑value = 0.0001).
Reliable results for TB infection, Greater ability to detect Mycobacterium tuberculosis infected persons |
Tuberculosis (TB) remains a major global health problem and a leading cause of death worldwide with close to 4000 lives a day. It causes approximately 10 million new cases each year. TB is a communicable disease caused by infection with Mycobacterium tuberculosis. TB is transmitted from person to person, for example when people with pulmonary TB expel bacteria by coughing. With a timely diagnostic and an adapted antibiotic treatment, most people who develop TB disease can be cured.
1.https://www.who.int/teams/global-tuberculosis-programme/tb-reports
2.https://www.ecdc.europa.eu/en/tuberculosis
A priority to:
CE Marked. Other health authorities approvals pending